| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87317094d61c68f4e07a50a5100546b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3415a602d027daf6549ca9c3d2c5298 |
| publicationDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006003335-A1 |
| titleOfInvention |
Methods for diagnosing acute megakaryoblastic leukemia |
| abstract |
The present invention is directed to methods and compositions for use in the diagnosis of acute megakaryoblastic leukemia. More particularly, it is shown that mutations in exon 2 of GATA-1 correlated with a predisposition to acute megakaryoblastic leukemia. Methods and compositions for exploiting this finding are described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012016030-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11197295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9629155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9769824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9307536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009162863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10244529-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015085945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012016030-A2 |
| priorityDate |
2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |